Oncología Traslacional
ONCTRAS
University of Paris-Sorbonne
París, FranciaUniversity of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2020
-
PARP inhibitors in ovarian cancer
New England Journal of Medicine
2017
-
Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial
Gynecologic Oncology, Vol. 144, Núm. 1, pp. 65-71
2016
-
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients
European Journal of Cancer, Vol. 69, pp. 127-134
2014
-
Gynecologic cancer intergroup (GCIG) consensus review for squamous cell carcinoma of the ovary
International Journal of Gynecological Cancer, Vol. 24, Núm. 9, pp. S26-S29